JP2016525092A5 - - Google Patents

Download PDF

Info

Publication number
JP2016525092A5
JP2016525092A5 JP2016524330A JP2016524330A JP2016525092A5 JP 2016525092 A5 JP2016525092 A5 JP 2016525092A5 JP 2016524330 A JP2016524330 A JP 2016524330A JP 2016524330 A JP2016524330 A JP 2016524330A JP 2016525092 A5 JP2016525092 A5 JP 2016525092A5
Authority
JP
Japan
Prior art keywords
pyrrole
methyl
carboxylate
octahydropyrrolo
hexafluoropropan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016524330A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016525092A (ja
JP6647592B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/045145 external-priority patent/WO2015003002A1/en
Publication of JP2016525092A publication Critical patent/JP2016525092A/ja
Publication of JP2016525092A5 publication Critical patent/JP2016525092A5/ja
Application granted granted Critical
Publication of JP6647592B2 publication Critical patent/JP6647592B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016524330A 2013-07-03 2014-07-01 ピロロピロールカルバメート、および関連する有機化合物、医薬組成物、ならびにその医学的使用 Expired - Fee Related JP6647592B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361842543P 2013-07-03 2013-07-03
US61/842,543 2013-07-03
PCT/US2014/045145 WO2015003002A1 (en) 2013-07-03 2014-07-01 Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof

Publications (3)

Publication Number Publication Date
JP2016525092A JP2016525092A (ja) 2016-08-22
JP2016525092A5 true JP2016525092A5 (cg-RX-API-DMAC7.html) 2017-08-10
JP6647592B2 JP6647592B2 (ja) 2020-02-14

Family

ID=52144176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016524330A Expired - Fee Related JP6647592B2 (ja) 2013-07-03 2014-07-01 ピロロピロールカルバメート、および関連する有機化合物、医薬組成物、ならびにその医学的使用

Country Status (7)

Country Link
US (1) US9828379B2 (cg-RX-API-DMAC7.html)
EP (1) EP3016653A4 (cg-RX-API-DMAC7.html)
JP (1) JP6647592B2 (cg-RX-API-DMAC7.html)
CN (1) CN105517547A (cg-RX-API-DMAC7.html)
CA (1) CA2917050A1 (cg-RX-API-DMAC7.html)
MX (1) MX2015017961A (cg-RX-API-DMAC7.html)
WO (1) WO2015003002A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2982694T3 (es) 2012-01-06 2024-10-17 H Lundbeck As Compuestos de carbamato para su uso en tratamiento
WO2015003002A1 (en) 2013-07-03 2015-01-08 Abide Therapeutics, Inc. Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
JP6832914B2 (ja) * 2015-07-31 2021-02-24 ファイザー・インク Magl阻害薬としての1,1,1−トリフルオロ−3−ヒドロキシプロパン−2−イルカルバマート誘導体および1,1,1−トリフルオロ−4−ヒドロキシブタン−2−イルカルバマート誘導体
US10463753B2 (en) 2016-02-19 2019-11-05 Lundbeck La Jolla Research Center, Inc. Radiolabeled monoacylglycerol lipase occupancy probe
US10030020B2 (en) 2016-05-12 2018-07-24 Abide Therapeutics, Inc. Spirocycle compounds and methods of making and using same
WO2018053447A1 (en) * 2016-09-19 2018-03-22 Abide Therapeutics, Inc. Piperazine carbamates and methods of making and using same
HUE056973T2 (hu) 2016-11-16 2022-04-28 H Lundbeck As MAGL inhibitor kristályos formája
CA3043609A1 (en) * 2016-11-16 2018-05-24 Abide Therapeutics, Inc. Pharmaceutical formulations
JOP20190105A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
JOP20190106A1 (ar) * 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
JOP20190107A1 (ar) * 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
CA3050625C (en) * 2017-01-20 2021-07-20 Pfizer Inc. 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors
HRP20241558T1 (hr) * 2017-03-13 2025-03-28 Lundbeck La Jolla Research Center, Inc. Dvojni inhibitori magl i faah
EP3675847B1 (en) 2017-08-29 2023-07-12 H. Lundbeck A/S Spirocycle compounds and methods of making and using same
EP3675848B1 (en) * 2017-08-29 2022-03-23 H. Lundbeck A/S Spirocycle compounds and methods of making and using same
CA3076477A1 (en) * 2017-09-29 2019-04-04 Takeda Pharmaceutical Company Limited Heterocyclic compound
JOP20200276A1 (ar) 2018-05-15 2020-11-02 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
US20210309669A1 (en) * 2018-07-19 2021-10-07 Pfizer Inc. Heterocyclic Spiro Compounds As MAGL Inhibitors
WO2021062232A1 (en) * 2019-09-26 2021-04-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for reducing rewarding effects of morphine without affecting its analgesic effects
MX2022013224A (es) 2020-04-21 2022-11-14 H Lundbeck As Sintesis de un inhibidor de la monoacilglicerol lipasa.
US11434222B2 (en) 2020-11-13 2022-09-06 H. Lundbeck A/S MAGL inhibitors
AU2022251752A1 (en) * 2021-04-01 2023-10-12 Ono Pharmaceutical Co., Ltd. Abhd6 antagonist
KR20240128870A (ko) 2021-12-29 2024-08-27 싸이 테라퓨틱스, 인크. 모노아실글리세롤 리파아제(magl) 억제
AU2023264787A1 (en) 2022-05-04 2024-10-31 H. Lundbeck A/S Crystalline form of 1,1,1,3,3,3-hexafluoropropan-2-yl (s)-1-(pyridazin-3-ylcarbamoyl)-6 azaspiro[2.5]octane-6-carboxylate as monoacylglycerol lipase inhibitor.
JP2024052624A (ja) * 2022-09-30 2024-04-11 小野薬品工業株式会社 Abhd6アンタゴニストを含有する医薬組成物
WO2024168426A1 (en) 2023-02-13 2024-08-22 Apogee Pharmaceuticals, Inc. Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
EP1368354A1 (en) * 2001-03-07 2003-12-10 Pfizer Products Inc. Modulators of chemokine receptor activity
CA2716863A1 (en) * 2008-03-05 2009-09-11 Targacept, Inc. Sub-type selective amides of diazabicycloalkanes
MX2012004753A (es) 2009-10-23 2012-09-07 Janssen Pharmaceutica Nv Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina.
JP2013521290A (ja) * 2010-03-04 2013-06-10 メルク・シャープ・エンド・ドーム・コーポレイション Mglur2の正のアロステリックモジュレータ
EP2444084A1 (en) * 2010-10-21 2012-04-25 Centro Nacional de Investigaciones Oncológicas (CNIO) Use of PI3K inibitors for the treatment of obesity
PL2900669T3 (pl) 2012-09-25 2020-01-31 F. Hoffmann-La Roche Ag Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek
WO2015003002A1 (en) 2013-07-03 2015-01-08 Abide Therapeutics, Inc. Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof

Similar Documents

Publication Publication Date Title
JP2016525092A5 (cg-RX-API-DMAC7.html)
US12331056B2 (en) SHP2 phosphatase inhibitors and methods of use thereof
JP2018500376A5 (cg-RX-API-DMAC7.html)
JP6435323B2 (ja) 炎症性障害の治療のための新規化合物及びその医薬組成物
SI3083625T1 (en) Pyrimidopyrimidinones, useful as Wee-1 kinase inhibitors
JP2013523884A5 (cg-RX-API-DMAC7.html)
JP2019535664A5 (cg-RX-API-DMAC7.html)
HRP20200575T1 (hr) Spojevi karbamata i postupci pripremanja i korištenja istih
JP2011511034A5 (cg-RX-API-DMAC7.html)
JP2015510938A5 (cg-RX-API-DMAC7.html)
JP2021506858A5 (cg-RX-API-DMAC7.html)
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2011516558A5 (cg-RX-API-DMAC7.html)
FI3436461T3 (fi) Pyrrolotriatsiiniyhdisteitä tam-inhibiittoreina
JP2014506929A5 (cg-RX-API-DMAC7.html)
JPWO2020005873A5 (cg-RX-API-DMAC7.html)
JP2017530960A5 (cg-RX-API-DMAC7.html)
RU2017105296A (ru) Новые соединения
HRP20210935T1 (hr) Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
RU2005117383A (ru) Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета
JPWO2020005877A5 (cg-RX-API-DMAC7.html)
JP2014511355A5 (cg-RX-API-DMAC7.html)
RU2008145504A (ru) Новое соединение пиперазина и его применение в качестве ингибитора hcv полимеразы
US20230406860A1 (en) Heterocyclic spiro compounds and methods of use
RU2013136778A (ru) Ингибиторы гистондезацетилазы, композиции и способы их применения